nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—Desmopressin—PTGS1—kidney cancer	0.00149	0.636	CrCbGaD
Octreotide—Desmopressin—PTGS2—kidney cancer	0.00085	0.364	CrCbGaD
Octreotide—SSTR4—Signaling Pathways—CTNNA1—kidney cancer	0.000335	0.00213	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HSPB1—kidney cancer	0.000333	0.00211	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EIF4EBP1—kidney cancer	0.000333	0.00211	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKAP13—kidney cancer	0.00033	0.00209	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP2—kidney cancer	0.00033	0.00209	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—POMC—kidney cancer	0.000323	0.00205	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SFRP2—kidney cancer	0.000321	0.00204	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKAP13—kidney cancer	0.000316	0.002	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP2—kidney cancer	0.000316	0.002	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—ANXA1—kidney cancer	0.000312	0.00198	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PSMD7—kidney cancer	0.00031	0.00197	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ANXA1—kidney cancer	0.00031	0.00197	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TSC1—kidney cancer	0.00031	0.00197	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GRB7—kidney cancer	0.000301	0.00191	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FLT1—kidney cancer	0.0003	0.0019	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—POMC—kidney cancer	0.000298	0.00189	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GRB7—kidney cancer	0.000289	0.00183	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—POMC—kidney cancer	0.000283	0.0018	CbGpPWpGaD
Octreotide—Anxiety—Paclitaxel—kidney cancer	0.000281	0.000335	CcSEcCtD
Octreotide—Decreased appetite—Gemcitabine—kidney cancer	0.000281	0.000334	CcSEcCtD
Octreotide—Hypersensitivity—Dactinomycin—kidney cancer	0.000281	0.000334	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00028	0.000334	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—AKAP13—kidney cancer	0.00028	0.00178	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ITPR2—kidney cancer	0.00028	0.00178	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP2—kidney cancer	0.00028	0.00178	CbGpPWpGaD
Octreotide—Arrhythmia—Capecitabine—kidney cancer	0.000279	0.000332	CcSEcCtD
Octreotide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000279	0.000332	CcSEcCtD
Octreotide—Discomfort—Paclitaxel—kidney cancer	0.000279	0.000332	CcSEcCtD
Octreotide—Fatigue—Gemcitabine—kidney cancer	0.000279	0.000332	CcSEcCtD
Octreotide—Gastrointestinal pain—Vincristine—kidney cancer	0.000279	0.000332	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—JUNB—kidney cancer	0.000278	0.00176	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PAK1—kidney cancer	0.000278	0.00176	CbGpPWpGaD
Octreotide—Dizziness—Sorafenib—kidney cancer	0.000277	0.00033	CcSEcCtD
Octreotide—Constipation—Gemcitabine—kidney cancer	0.000276	0.000329	CcSEcCtD
Octreotide—Pain—Gemcitabine—kidney cancer	0.000276	0.000329	CcSEcCtD
Octreotide—Nausea—Erlotinib—kidney cancer	0.000276	0.000329	CcSEcCtD
Octreotide—Alopecia—Capecitabine—kidney cancer	0.000276	0.000329	CcSEcCtD
Octreotide—Dry mouth—Paclitaxel—kidney cancer	0.000276	0.000329	CcSEcCtD
Octreotide—Diarrhoea—Sunitinib—kidney cancer	0.000276	0.000328	CcSEcCtD
Octreotide—Mental disorder—Capecitabine—kidney cancer	0.000274	0.000326	CcSEcCtD
Octreotide—Asthenia—Dactinomycin—kidney cancer	0.000274	0.000326	CcSEcCtD
Octreotide—Malnutrition—Capecitabine—kidney cancer	0.000272	0.000324	CcSEcCtD
Octreotide—Erythema—Capecitabine—kidney cancer	0.000272	0.000324	CcSEcCtD
Octreotide—Dehydration—Doxorubicin—kidney cancer	0.000271	0.000322	CcSEcCtD
Octreotide—Oedema—Paclitaxel—kidney cancer	0.000271	0.000322	CcSEcCtD
Octreotide—Anaphylactic shock—Paclitaxel—kidney cancer	0.000271	0.000322	CcSEcCtD
Octreotide—Abdominal pain—Vincristine—kidney cancer	0.000269	0.000321	CcSEcCtD
Octreotide—Body temperature increased—Vincristine—kidney cancer	0.000269	0.000321	CcSEcCtD
Octreotide—Infection—Paclitaxel—kidney cancer	0.000269	0.00032	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—ITPR2—kidney cancer	0.000269	0.0017	CbGpPWpGaD
Octreotide—Flatulence—Capecitabine—kidney cancer	0.000268	0.000319	CcSEcCtD
Octreotide—Dry skin—Doxorubicin—kidney cancer	0.000267	0.000318	CcSEcCtD
Octreotide—Dizziness—Sunitinib—kidney cancer	0.000266	0.000317	CcSEcCtD
Octreotide—Feeling abnormal—Gemcitabine—kidney cancer	0.000266	0.000317	CcSEcCtD
Octreotide—Shock—Paclitaxel—kidney cancer	0.000266	0.000317	CcSEcCtD
Octreotide—Vomiting—Sorafenib—kidney cancer	0.000266	0.000317	CcSEcCtD
Octreotide—Abdominal pain upper—Doxorubicin—kidney cancer	0.000266	0.000317	CcSEcCtD
Octreotide—Nervous system disorder—Paclitaxel—kidney cancer	0.000265	0.000316	CcSEcCtD
Octreotide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000265	0.000315	CcSEcCtD
Octreotide—Tachycardia—Paclitaxel—kidney cancer	0.000264	0.000314	CcSEcCtD
Octreotide—Rash—Sorafenib—kidney cancer	0.000264	0.000314	CcSEcCtD
Octreotide—Dermatitis—Sorafenib—kidney cancer	0.000264	0.000314	CcSEcCtD
Octreotide—Back pain—Capecitabine—kidney cancer	0.000263	0.000313	CcSEcCtD
Octreotide—Skin disorder—Paclitaxel—kidney cancer	0.000263	0.000313	CcSEcCtD
Octreotide—Headache—Sorafenib—kidney cancer	0.000262	0.000312	CcSEcCtD
Octreotide—Muscle spasms—Capecitabine—kidney cancer	0.000262	0.000311	CcSEcCtD
Octreotide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000262	0.000311	CcSEcCtD
Octreotide—Diarrhoea—Dactinomycin—kidney cancer	0.000261	0.000311	CcSEcCtD
Octreotide—Nasopharyngitis—Doxorubicin—kidney cancer	0.00026	0.00031	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CASP2—kidney cancer	0.000259	0.00164	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKAP13—kidney cancer	0.000259	0.00164	CbGpPWpGaD
Octreotide—Anorexia—Paclitaxel—kidney cancer	0.000258	0.000307	CcSEcCtD
Octreotide—Gastritis—Doxorubicin—kidney cancer	0.000258	0.000307	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—POMC—kidney cancer	0.000257	0.00163	CbGpPWpGaD
Octreotide—Muscular weakness—Doxorubicin—kidney cancer	0.000257	0.000306	CcSEcCtD
Octreotide—Vision blurred—Capecitabine—kidney cancer	0.000256	0.000305	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—GRB7—kidney cancer	0.000256	0.00163	CbGpPWpGaD
Octreotide—Vomiting—Sunitinib—kidney cancer	0.000256	0.000305	CcSEcCtD
Octreotide—Body temperature increased—Gemcitabine—kidney cancer	0.000256	0.000304	CcSEcCtD
Octreotide—Tremor—Capecitabine—kidney cancer	0.000255	0.000303	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CTNNA1—kidney cancer	0.000254	0.00161	CbGpPWpGaD
Octreotide—Rash—Sunitinib—kidney cancer	0.000254	0.000302	CcSEcCtD
Octreotide—Dermatitis—Sunitinib—kidney cancer	0.000254	0.000302	CcSEcCtD
Octreotide—Abdominal distension—Doxorubicin—kidney cancer	0.000253	0.000302	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—HSPB1—kidney cancer	0.000253	0.0016	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EIF4EBP1—kidney cancer	0.000253	0.0016	CbGpPWpGaD
Octreotide—Ill-defined disorder—Capecitabine—kidney cancer	0.000252	0.000301	CcSEcCtD
Octreotide—Headache—Sunitinib—kidney cancer	0.000252	0.0003	CcSEcCtD
Octreotide—Asthma—Doxorubicin—kidney cancer	0.000252	0.0003	CcSEcCtD
Octreotide—Influenza—Doxorubicin—kidney cancer	0.000252	0.0003	CcSEcCtD
Octreotide—Anaemia—Capecitabine—kidney cancer	0.000252	0.000299	CcSEcCtD
Octreotide—Hypersensitivity—Vincristine—kidney cancer	0.000251	0.000299	CcSEcCtD
Octreotide—Nausea—Sorafenib—kidney cancer	0.000249	0.000296	CcSEcCtD
Octreotide—Pancreatitis—Doxorubicin—kidney cancer	0.000247	0.000294	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000247	0.000294	CcSEcCtD
Octreotide—Malaise—Capecitabine—kidney cancer	0.000245	0.000292	CcSEcCtD
Octreotide—Insomnia—Paclitaxel—kidney cancer	0.000245	0.000291	CcSEcCtD
Octreotide—Vertigo—Capecitabine—kidney cancer	0.000244	0.000291	CcSEcCtD
Octreotide—Asthenia—Vincristine—kidney cancer	0.000244	0.000291	CcSEcCtD
Octreotide—Syncope—Capecitabine—kidney cancer	0.000244	0.00029	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CTNNA1—kidney cancer	0.000244	0.00155	CbGpPWpGaD
Octreotide—Paraesthesia—Paclitaxel—kidney cancer	0.000243	0.000289	CcSEcCtD
Octreotide—Vomiting—Dactinomycin—kidney cancer	0.000242	0.000289	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—EIF4EBP1—kidney cancer	0.000242	0.00154	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HSPB1—kidney cancer	0.000242	0.00154	CbGpPWpGaD
Octreotide—Bronchitis—Doxorubicin—kidney cancer	0.000242	0.000288	CcSEcCtD
Octreotide—Dyspnoea—Paclitaxel—kidney cancer	0.000241	0.000287	CcSEcCtD
Octreotide—Somnolence—Paclitaxel—kidney cancer	0.000241	0.000286	CcSEcCtD
Octreotide—Palpitations—Capecitabine—kidney cancer	0.00024	0.000286	CcSEcCtD
Octreotide—Rash—Dactinomycin—kidney cancer	0.00024	0.000286	CcSEcCtD
Octreotide—Nausea—Sunitinib—kidney cancer	0.000239	0.000285	CcSEcCtD
Octreotide—Loss of consciousness—Capecitabine—kidney cancer	0.000239	0.000285	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—ITPR2—kidney cancer	0.000238	0.00151	CbGpPWpGaD
Octreotide—Dyspepsia—Paclitaxel—kidney cancer	0.000238	0.000284	CcSEcCtD
Octreotide—Cough—Capecitabine—kidney cancer	0.000237	0.000283	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GRB7—kidney cancer	0.000236	0.0015	CbGpPWpGaD
Octreotide—Dysuria—Doxorubicin—kidney cancer	0.000235	0.00028	CcSEcCtD
Octreotide—Decreased appetite—Paclitaxel—kidney cancer	0.000235	0.00028	CcSEcCtD
Octreotide—Hypertension—Capecitabine—kidney cancer	0.000235	0.00028	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—ANXA1—kidney cancer	0.000235	0.00149	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TSC1—kidney cancer	0.000235	0.00149	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PSMD7—kidney cancer	0.000235	0.00149	CbGpPWpGaD
Octreotide—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000234	0.000279	CcSEcCtD
Octreotide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000234	0.000278	CcSEcCtD
Octreotide—Fatigue—Paclitaxel—kidney cancer	0.000233	0.000278	CcSEcCtD
Octreotide—Diarrhoea—Vincristine—kidney cancer	0.000233	0.000278	CcSEcCtD
Octreotide—Pollakiuria—Doxorubicin—kidney cancer	0.000233	0.000277	CcSEcCtD
Octreotide—Asthenia—Gemcitabine—kidney cancer	0.000232	0.000276	CcSEcCtD
Octreotide—Myalgia—Capecitabine—kidney cancer	0.000232	0.000276	CcSEcCtD
Octreotide—Arthralgia—Capecitabine—kidney cancer	0.000232	0.000276	CcSEcCtD
Octreotide—Chest pain—Capecitabine—kidney cancer	0.000232	0.000276	CcSEcCtD
Octreotide—Constipation—Paclitaxel—kidney cancer	0.000231	0.000275	CcSEcCtD
Octreotide—Pain—Paclitaxel—kidney cancer	0.000231	0.000275	CcSEcCtD
Octreotide—Anxiety—Capecitabine—kidney cancer	0.000231	0.000275	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00023	0.000274	CcSEcCtD
Octreotide—Weight increased—Doxorubicin—kidney cancer	0.000229	0.000273	CcSEcCtD
Octreotide—Discomfort—Capecitabine—kidney cancer	0.000229	0.000272	CcSEcCtD
Octreotide—Pruritus—Gemcitabine—kidney cancer	0.000229	0.000272	CcSEcCtD
Octreotide—Weight decreased—Doxorubicin—kidney cancer	0.000228	0.000271	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—FLT1—kidney cancer	0.000227	0.00144	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IGF2—kidney cancer	0.000227	0.00144	CbGpPWpGaD
Octreotide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000227	0.00027	CcSEcCtD
Octreotide—Dry mouth—Capecitabine—kidney cancer	0.000227	0.00027	CcSEcCtD
Octreotide—Nausea—Dactinomycin—kidney cancer	0.000227	0.00027	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CDKN2B—kidney cancer	0.000226	0.00144	CbGpPWpGaD
Octreotide—Pneumonia—Doxorubicin—kidney cancer	0.000226	0.000269	CcSEcCtD
Octreotide—Dizziness—Vincristine—kidney cancer	0.000225	0.000268	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—ANXA1—kidney cancer	0.000225	0.00143	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TSC1—kidney cancer	0.000225	0.00143	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PSMD7—kidney cancer	0.000225	0.00143	CbGpPWpGaD
Octreotide—Drowsiness—Doxorubicin—kidney cancer	0.000224	0.000267	CcSEcCtD
Octreotide—Feeling abnormal—Paclitaxel—kidney cancer	0.000223	0.000265	CcSEcCtD
Octreotide—Oedema—Capecitabine—kidney cancer	0.000222	0.000264	CcSEcCtD
Octreotide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000221	0.000263	CcSEcCtD
Octreotide—Diarrhoea—Gemcitabine—kidney cancer	0.000221	0.000263	CcSEcCtD
Octreotide—Infection—Capecitabine—kidney cancer	0.000221	0.000263	CcSEcCtD
Octreotide—Neuropathy peripheral—Doxorubicin—kidney cancer	0.00022	0.000262	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—ITPR2—kidney cancer	0.00022	0.0014	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IGF1R—kidney cancer	0.00022	0.0014	CbGpPWpGaD
Octreotide—Jaundice—Doxorubicin—kidney cancer	0.000219	0.00026	CcSEcCtD
Octreotide—Shock—Capecitabine—kidney cancer	0.000219	0.00026	CcSEcCtD
Octreotide—Urinary tract infection—Doxorubicin—kidney cancer	0.000218	0.00026	CcSEcCtD
Octreotide—Conjunctivitis—Doxorubicin—kidney cancer	0.000218	0.00026	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—FLT1—kidney cancer	0.000218	0.00138	CbGpPWpGaD
Octreotide—Nervous system disorder—Capecitabine—kidney cancer	0.000218	0.000259	CcSEcCtD
Octreotide—Thrombocytopenia—Capecitabine—kidney cancer	0.000217	0.000259	CcSEcCtD
Octreotide—Tachycardia—Capecitabine—kidney cancer	0.000217	0.000258	CcSEcCtD
Octreotide—Vomiting—Vincristine—kidney cancer	0.000217	0.000258	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CTNNA1—kidney cancer	0.000216	0.00137	CbGpPWpGaD
Octreotide—Skin disorder—Capecitabine—kidney cancer	0.000216	0.000257	CcSEcCtD
Octreotide—Urticaria—Paclitaxel—kidney cancer	0.000215	0.000256	CcSEcCtD
Octreotide—Rash—Vincristine—kidney cancer	0.000215	0.000256	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—EIF4EBP1—kidney cancer	0.000215	0.00136	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HSPB1—kidney cancer	0.000215	0.00136	CbGpPWpGaD
Octreotide—Hyperhidrosis—Capecitabine—kidney cancer	0.000215	0.000256	CcSEcCtD
Octreotide—Dermatitis—Vincristine—kidney cancer	0.000215	0.000256	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—POMC—kidney cancer	0.000214	0.00136	CbGpPWpGaD
Octreotide—Haematuria—Doxorubicin—kidney cancer	0.000214	0.000255	CcSEcCtD
Octreotide—Abdominal pain—Paclitaxel—kidney cancer	0.000214	0.000255	CcSEcCtD
Octreotide—Body temperature increased—Paclitaxel—kidney cancer	0.000214	0.000255	CcSEcCtD
Octreotide—Headache—Vincristine—kidney cancer	0.000213	0.000254	CcSEcCtD
Octreotide—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000212	0.000253	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—RAF1—kidney cancer	0.000212	0.00134	CbGpPWpGaD
Octreotide—Epistaxis—Doxorubicin—kidney cancer	0.000212	0.000252	CcSEcCtD
Octreotide—Anorexia—Capecitabine—kidney cancer	0.000212	0.000252	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—JUNB—kidney cancer	0.000211	0.00134	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PAK1—kidney cancer	0.000211	0.00134	CbGpPWpGaD
Octreotide—Sinusitis—Doxorubicin—kidney cancer	0.000211	0.000251	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—IL2—kidney cancer	0.000209	0.00133	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—POMC—kidney cancer	0.000206	0.0013	CbGpPWpGaD
Octreotide—Vomiting—Gemcitabine—kidney cancer	0.000206	0.000245	CcSEcCtD
Octreotide—Bradycardia—Doxorubicin—kidney cancer	0.000205	0.000244	CcSEcCtD
Octreotide—Rash—Gemcitabine—kidney cancer	0.000204	0.000243	CcSEcCtD
Octreotide—Dermatitis—Gemcitabine—kidney cancer	0.000204	0.000242	CcSEcCtD
Octreotide—Headache—Gemcitabine—kidney cancer	0.000202	0.000241	CcSEcCtD
Octreotide—Nausea—Vincristine—kidney cancer	0.000202	0.000241	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000202	0.000241	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PAK1—kidney cancer	0.000202	0.00128	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JUNB—kidney cancer	0.000202	0.00128	CbGpPWpGaD
Octreotide—Rhinitis—Doxorubicin—kidney cancer	0.000202	0.00024	CcSEcCtD
Octreotide—Hepatitis—Doxorubicin—kidney cancer	0.000202	0.00024	CcSEcCtD
Octreotide—Insomnia—Capecitabine—kidney cancer	0.000201	0.000239	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—kidney cancer	0.0002	0.000239	CcSEcCtD
Octreotide—Pharyngitis—Doxorubicin—kidney cancer	0.0002	0.000238	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—TSC1—kidney cancer	0.0002	0.00127	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PSMD7—kidney cancer	0.0002	0.00127	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ANXA1—kidney cancer	0.0002	0.00127	CbGpPWpGaD
Octreotide—Paraesthesia—Capecitabine—kidney cancer	0.000199	0.000237	CcSEcCtD
Octreotide—Hypersensitivity—Paclitaxel—kidney cancer	0.000199	0.000237	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CTNNA1—kidney cancer	0.000199	0.00126	CbGpPWpGaD
Octreotide—Oedema peripheral—Doxorubicin—kidney cancer	0.000199	0.000236	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—EIF4EBP1—kidney cancer	0.000198	0.00126	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HSPB1—kidney cancer	0.000198	0.00126	CbGpPWpGaD
Octreotide—Dyspnoea—Capecitabine—kidney cancer	0.000198	0.000236	CcSEcCtD
Octreotide—Dyspepsia—Capecitabine—kidney cancer	0.000195	0.000233	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—POMC—kidney cancer	0.000195	0.00124	CbGpPWpGaD
Octreotide—Visual impairment—Doxorubicin—kidney cancer	0.000194	0.000231	CcSEcCtD
Octreotide—Asthenia—Paclitaxel—kidney cancer	0.000194	0.000231	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—FLT1—kidney cancer	0.000193	0.00123	CbGpPWpGaD
Octreotide—Decreased appetite—Capecitabine—kidney cancer	0.000193	0.00023	CcSEcCtD
Octreotide—Nausea—Gemcitabine—kidney cancer	0.000192	0.000229	CcSEcCtD
Octreotide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000192	0.000228	CcSEcCtD
Octreotide—Fatigue—Capecitabine—kidney cancer	0.000191	0.000228	CcSEcCtD
Octreotide—Pruritus—Paclitaxel—kidney cancer	0.000191	0.000228	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—IL2—kidney cancer	0.00019	0.00121	CbGpPWpGaD
Octreotide—Pain—Capecitabine—kidney cancer	0.00019	0.000226	CcSEcCtD
Octreotide—Constipation—Capecitabine—kidney cancer	0.00019	0.000226	CcSEcCtD
Octreotide—Tinnitus—Doxorubicin—kidney cancer	0.000188	0.000224	CcSEcCtD
Octreotide—Flushing—Doxorubicin—kidney cancer	0.000187	0.000223	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—kidney cancer	0.000187	0.000223	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—POMC—kidney cancer	0.000187	0.00118	CbGpPWpGaD
Octreotide—Diarrhoea—Paclitaxel—kidney cancer	0.000185	0.00022	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PSMD7—kidney cancer	0.000184	0.00117	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ANXA1—kidney cancer	0.000184	0.00117	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TSC1—kidney cancer	0.000184	0.00117	CbGpPWpGaD
Octreotide—Feeling abnormal—Capecitabine—kidney cancer	0.000183	0.000218	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—POMC—kidney cancer	0.000182	0.00116	CbGpPWpGaD
Octreotide—Immune system disorder—Doxorubicin—kidney cancer	0.000182	0.000217	CcSEcCtD
Octreotide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000182	0.000216	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—HIF1A—kidney cancer	0.000181	0.00115	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TSC2—kidney cancer	0.000181	0.00115	CbGpPWpGaD
Octreotide—Arrhythmia—Doxorubicin—kidney cancer	0.00018	0.000214	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—JUNB—kidney cancer	0.000179	0.00114	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PAK1—kidney cancer	0.000179	0.00114	CbGpPWpGaD
Octreotide—Dizziness—Paclitaxel—kidney cancer	0.000179	0.000213	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—FLT1—kidney cancer	0.000178	0.00113	CbGpPWpGaD
Octreotide—Alopecia—Doxorubicin—kidney cancer	0.000178	0.000212	CcSEcCtD
Octreotide—Mental disorder—Doxorubicin—kidney cancer	0.000177	0.00021	CcSEcCtD
Octreotide—Urticaria—Capecitabine—kidney cancer	0.000176	0.00021	CcSEcCtD
Octreotide—Body temperature increased—Capecitabine—kidney cancer	0.000176	0.000209	CcSEcCtD
Octreotide—Abdominal pain—Capecitabine—kidney cancer	0.000176	0.000209	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—kidney cancer	0.000175	0.000209	CcSEcCtD
Octreotide—Erythema—Doxorubicin—kidney cancer	0.000175	0.000209	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—KDR—kidney cancer	0.000173	0.0011	CbGpPWpGaD
Octreotide—Flatulence—Doxorubicin—kidney cancer	0.000173	0.000206	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—IGF2—kidney cancer	0.000172	0.00109	CbGpPWpGaD
Octreotide—Tension—Doxorubicin—kidney cancer	0.000172	0.000205	CcSEcCtD
Octreotide—Vomiting—Paclitaxel—kidney cancer	0.000172	0.000205	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CDKN2B—kidney cancer	0.000172	0.00109	CbGpPWpGaD
Octreotide—Rash—Paclitaxel—kidney cancer	0.000171	0.000203	CcSEcCtD
Octreotide—Dermatitis—Paclitaxel—kidney cancer	0.00017	0.000203	CcSEcCtD
Octreotide—Nervousness—Doxorubicin—kidney cancer	0.00017	0.000203	CcSEcCtD
Octreotide—Back pain—Doxorubicin—kidney cancer	0.00017	0.000202	CcSEcCtD
Octreotide—Headache—Paclitaxel—kidney cancer	0.00017	0.000202	CcSEcCtD
Octreotide—Muscle spasms—Doxorubicin—kidney cancer	0.000169	0.000201	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—POMC—kidney cancer	0.000168	0.00107	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1R—kidney cancer	0.000167	0.00106	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—POMC—kidney cancer	0.000166	0.00105	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PAK1—kidney cancer	0.000165	0.00105	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JUNB—kidney cancer	0.000165	0.00105	CbGpPWpGaD
Octreotide—Vision blurred—Doxorubicin—kidney cancer	0.000165	0.000197	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—IGF2—kidney cancer	0.000165	0.00105	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN2B—kidney cancer	0.000165	0.00104	CbGpPWpGaD
Octreotide—Hypersensitivity—Capecitabine—kidney cancer	0.000164	0.000195	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000163	0.000194	CcSEcCtD
Octreotide—Anaemia—Doxorubicin—kidney cancer	0.000162	0.000193	CcSEcCtD
Octreotide—Agitation—Doxorubicin—kidney cancer	0.000161	0.000192	CcSEcCtD
Octreotide—Nausea—Paclitaxel—kidney cancer	0.000161	0.000191	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—RAF1—kidney cancer	0.000161	0.00102	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1R—kidney cancer	0.00016	0.00101	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APC—kidney cancer	0.000159	0.00101	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KIT—kidney cancer	0.000159	0.00101	CbGpPWpGaD
Octreotide—Asthenia—Capecitabine—kidney cancer	0.000159	0.00019	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—IL2—kidney cancer	0.000159	0.00101	CbGpPWpGaD
Octreotide—Malaise—Doxorubicin—kidney cancer	0.000158	0.000188	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—kidney cancer	0.000158	0.000188	CcSEcCtD
Octreotide—Syncope—Doxorubicin—kidney cancer	0.000157	0.000187	CcSEcCtD
Octreotide—Pruritus—Capecitabine—kidney cancer	0.000157	0.000187	CcSEcCtD
Octreotide—Palpitations—Doxorubicin—kidney cancer	0.000155	0.000185	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—kidney cancer	0.000154	0.000184	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—RAF1—kidney cancer	0.000154	0.000977	CbGpPWpGaD
Octreotide—Cough—Doxorubicin—kidney cancer	0.000153	0.000182	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—POMC—kidney cancer	0.000153	0.00097	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—MAPK3—kidney cancer	0.000153	0.000969	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2—kidney cancer	0.000152	0.000964	CbGpPWpGaD
Octreotide—Convulsion—Doxorubicin—kidney cancer	0.000152	0.000181	CcSEcCtD
Octreotide—Diarrhoea—Capecitabine—kidney cancer	0.000152	0.000181	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—POMC—kidney cancer	0.000152	0.000963	CbGpPWpGaD
Octreotide—Hypertension—Doxorubicin—kidney cancer	0.000151	0.00018	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—BRAF—kidney cancer	0.00015	0.000951	CbGpPWpGaD
Octreotide—Myalgia—Doxorubicin—kidney cancer	0.000149	0.000178	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—kidney cancer	0.000149	0.000178	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—kidney cancer	0.000149	0.000178	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—kidney cancer	0.000149	0.000177	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000148	0.000177	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—kidney cancer	0.000148	0.000176	CcSEcCtD
Octreotide—Dizziness—Capecitabine—kidney cancer	0.000147	0.000175	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—IGF2—kidney cancer	0.000147	0.00093	CbGpPWpGaD
Octreotide—Dry mouth—Doxorubicin—kidney cancer	0.000146	0.000174	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CDKN2B—kidney cancer	0.000146	0.000926	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—MAPK1—kidney cancer	0.000145	0.000922	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL2—kidney cancer	0.000144	0.000913	CbGpPWpGaD
Octreotide—Anaphylactic shock—Doxorubicin—kidney cancer	0.000143	0.00017	CcSEcCtD
Octreotide—Oedema—Doxorubicin—kidney cancer	0.000143	0.00017	CcSEcCtD
Octreotide—Infection—Doxorubicin—kidney cancer	0.000142	0.000169	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—IGF1R—kidney cancer	0.000142	0.000899	CbGpPWpGaD
Octreotide—Vomiting—Capecitabine—kidney cancer	0.000141	0.000168	CcSEcCtD
Octreotide—Shock—Doxorubicin—kidney cancer	0.000141	0.000168	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—kidney cancer	0.00014	0.000167	CcSEcCtD
Octreotide—Thrombocytopenia—Doxorubicin—kidney cancer	0.00014	0.000167	CcSEcCtD
Octreotide—Rash—Capecitabine—kidney cancer	0.00014	0.000167	CcSEcCtD
Octreotide—Dermatitis—Capecitabine—kidney cancer	0.00014	0.000167	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—kidney cancer	0.00014	0.000166	CcSEcCtD
Octreotide—Headache—Capecitabine—kidney cancer	0.000139	0.000166	CcSEcCtD
Octreotide—Skin disorder—Doxorubicin—kidney cancer	0.000139	0.000166	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—PIK3CA—kidney cancer	0.000139	0.000881	CbGpPWpGaD
Octreotide—Hyperhidrosis—Doxorubicin—kidney cancer	0.000138	0.000165	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—IL2—kidney cancer	0.000138	0.000876	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—KRAS—kidney cancer	0.000137	0.000871	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HIF1A—kidney cancer	0.000137	0.00087	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TSC2—kidney cancer	0.000137	0.000868	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—RAF1—kidney cancer	0.000137	0.000866	CbGpPWpGaD
Octreotide—Anorexia—Doxorubicin—kidney cancer	0.000136	0.000162	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—IGF2—kidney cancer	0.000135	0.000858	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—kidney cancer	0.000135	0.000855	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN2B—kidney cancer	0.000135	0.000854	CbGpPWpGaD
Octreotide—Nausea—Capecitabine—kidney cancer	0.000132	0.000157	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HIF1A—kidney cancer	0.000132	0.000834	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KDR—kidney cancer	0.000131	0.000832	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TSC2—kidney cancer	0.000131	0.000832	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1R—kidney cancer	0.000131	0.00083	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00013	0.000155	CcSEcCtD
Octreotide—Insomnia—Doxorubicin—kidney cancer	0.000129	0.000154	CcSEcCtD
Octreotide—Paraesthesia—Doxorubicin—kidney cancer	0.000129	0.000153	CcSEcCtD
Octreotide—Dyspnoea—Doxorubicin—kidney cancer	0.000128	0.000152	CcSEcCtD
Octreotide—Somnolence—Doxorubicin—kidney cancer	0.000127	0.000151	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—kidney cancer	0.000126	0.0008	CbGpPWpGaD
Octreotide—Dyspepsia—Doxorubicin—kidney cancer	0.000126	0.00015	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—RAF1—kidney cancer	0.000126	0.000799	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KDR—kidney cancer	0.000126	0.000798	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RAF1—kidney cancer	0.000125	0.000794	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RELA—kidney cancer	0.000125	0.000791	CbGpPWpGaD
Octreotide—Decreased appetite—Doxorubicin—kidney cancer	0.000124	0.000148	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—IL2—kidney cancer	0.000124	0.000789	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ERBB2—kidney cancer	0.000124	0.000786	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000124	0.000147	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—kidney cancer	0.000123	0.000147	CcSEcCtD
Octreotide—Constipation—Doxorubicin—kidney cancer	0.000122	0.000146	CcSEcCtD
Octreotide—Pain—Doxorubicin—kidney cancer	0.000122	0.000146	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—IL2—kidney cancer	0.000122	0.000777	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MTOR—kidney cancer	0.000122	0.000775	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—kidney cancer	0.000121	0.000767	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KIT—kidney cancer	0.000121	0.000767	CbGpPWpGaD
Octreotide—Feeling abnormal—Doxorubicin—kidney cancer	0.000118	0.00014	CcSEcCtD
Octreotide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000117	0.000139	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—HIF1A—kidney cancer	0.000117	0.00074	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TSC2—kidney cancer	0.000116	0.000738	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KIT—kidney cancer	0.000116	0.000735	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APC—kidney cancer	0.000116	0.000735	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK3—kidney cancer	0.000116	0.000734	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—POMC—kidney cancer	0.000115	0.00073	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1B—kidney cancer	0.000115	0.000728	CbGpPWpGaD
Octreotide—Urticaria—Doxorubicin—kidney cancer	0.000114	0.000135	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—BRAF—kidney cancer	0.000114	0.000721	CbGpPWpGaD
Octreotide—Body temperature increased—Doxorubicin—kidney cancer	0.000113	0.000135	CcSEcCtD
Octreotide—Abdominal pain—Doxorubicin—kidney cancer	0.000113	0.000135	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—IL2—kidney cancer	0.000113	0.000717	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—kidney cancer	0.000112	0.000712	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—kidney cancer	0.000112	0.000708	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK3—kidney cancer	0.000111	0.000704	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—POMC—kidney cancer	0.00011	0.0007	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK1—kidney cancer	0.00011	0.000699	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—kidney cancer	0.000109	0.000694	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—JUN—kidney cancer	0.000109	0.000693	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BRAF—kidney cancer	0.000109	0.000691	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—kidney cancer	0.000108	0.000687	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HIF1A—kidney cancer	0.000108	0.000683	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TSC2—kidney cancer	0.000107	0.000681	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTEN—kidney cancer	0.000106	0.00067	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK1—kidney cancer	0.000106	0.00067	CbGpPWpGaD
Octreotide—Hypersensitivity—Doxorubicin—kidney cancer	0.000105	0.000126	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—kidney cancer	0.000105	0.000668	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—kidney cancer	0.000104	0.00066	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—kidney cancer	0.000103	0.000653	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—kidney cancer	0.000103	0.000652	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KIT—kidney cancer	0.000103	0.000652	CbGpPWpGaD
Octreotide—Asthenia—Doxorubicin—kidney cancer	0.000103	0.000122	CcSEcCtD
Octreotide—Pruritus—Doxorubicin—kidney cancer	0.000101	0.000121	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—kidney cancer	0.000101	0.00064	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—kidney cancer	9.97e-05	0.000633	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK3—kidney cancer	9.84e-05	0.000624	CbGpPWpGaD
Octreotide—Diarrhoea—Doxorubicin—kidney cancer	9.8e-05	0.000117	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—POMC—kidney cancer	9.78e-05	0.000621	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BRAF—kidney cancer	9.66e-05	0.000613	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—kidney cancer	9.56e-05	0.000606	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—kidney cancer	9.54e-05	0.000605	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAF1—kidney cancer	9.48e-05	0.000602	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—kidney cancer	9.48e-05	0.000602	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KIT—kidney cancer	9.48e-05	0.000602	CbGpPWpGaD
Octreotide—Dizziness—Doxorubicin—kidney cancer	9.47e-05	0.000113	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—RELA—kidney cancer	9.44e-05	0.000599	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB2—kidney cancer	9.38e-05	0.000595	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK1—kidney cancer	9.36e-05	0.000594	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTOR—kidney cancer	9.26e-05	0.000588	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—kidney cancer	9.16e-05	0.000581	CbGpPWpGaD
Octreotide—Vomiting—Doxorubicin—kidney cancer	9.1e-05	0.000108	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—RAF1—kidney cancer	9.09e-05	0.000577	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK3—kidney cancer	9.08e-05	0.000576	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RELA—kidney cancer	9.05e-05	0.000574	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—POMC—kidney cancer	9.03e-05	0.000573	CbGpPWpGaD
Octreotide—Rash—Doxorubicin—kidney cancer	9.03e-05	0.000107	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MAPK3—kidney cancer	9.02e-05	0.000572	CbGpPWpGaD
Octreotide—Dermatitis—Doxorubicin—kidney cancer	9.02e-05	0.000107	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—ERBB2—kidney cancer	9e-05	0.000571	CbGpPWpGaD
Octreotide—Headache—Doxorubicin—kidney cancer	8.97e-05	0.000107	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—kidney cancer	8.95e-05	0.000568	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BRAF—kidney cancer	8.91e-05	0.000566	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MTOR—kidney cancer	8.88e-05	0.000563	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—kidney cancer	8.84e-05	0.000561	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—kidney cancer	8.77e-05	0.000557	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1B—kidney cancer	8.69e-05	0.000551	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK1—kidney cancer	8.64e-05	0.000548	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK1—kidney cancer	8.58e-05	0.000545	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—kidney cancer	8.5e-05	0.00054	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—kidney cancer	8.5e-05	0.000101	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CDKN1B—kidney cancer	8.33e-05	0.000529	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—kidney cancer	8.29e-05	0.000526	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JUN—kidney cancer	8.27e-05	0.000525	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—kidney cancer	8.26e-05	0.000524	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—kidney cancer	8.21e-05	0.000521	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—kidney cancer	8.16e-05	0.000518	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—kidney cancer	8.15e-05	0.000517	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—kidney cancer	8.13e-05	0.000516	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—kidney cancer	8.11e-05	0.000514	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAF1—kidney cancer	8.06e-05	0.000512	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RELA—kidney cancer	8.03e-05	0.000509	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTEN—kidney cancer	8e-05	0.000508	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB2—kidney cancer	7.98e-05	0.000506	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—kidney cancer	7.95e-05	0.000504	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JUN—kidney cancer	7.93e-05	0.000503	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTOR—kidney cancer	7.87e-05	0.0005	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—kidney cancer	7.87e-05	0.000499	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTEN—kidney cancer	7.67e-05	0.000487	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—kidney cancer	7.5e-05	0.000476	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—kidney cancer	7.45e-05	0.000473	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RAF1—kidney cancer	7.44e-05	0.000472	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RELA—kidney cancer	7.41e-05	0.00047	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1B—kidney cancer	7.39e-05	0.000469	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB2—kidney cancer	7.36e-05	0.000467	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTOR—kidney cancer	7.27e-05	0.000461	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—kidney cancer	7.23e-05	0.000459	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—kidney cancer	7.23e-05	0.000459	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—kidney cancer	7.21e-05	0.000457	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—kidney cancer	7.05e-05	0.000447	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JUN—kidney cancer	7.03e-05	0.000446	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—kidney cancer	6.98e-05	0.000443	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—kidney cancer	6.93e-05	0.00044	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK3—kidney cancer	6.84e-05	0.000434	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1B—kidney cancer	6.82e-05	0.000433	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTEN—kidney cancer	6.8e-05	0.000432	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—kidney cancer	6.67e-05	0.000423	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—kidney cancer	6.65e-05	0.000422	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK3—kidney cancer	6.55e-05	0.000416	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—kidney cancer	6.51e-05	0.000413	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK1—kidney cancer	6.51e-05	0.000413	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JUN—kidney cancer	6.49e-05	0.000412	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—kidney cancer	6.44e-05	0.000409	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—kidney cancer	6.38e-05	0.000405	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTEN—kidney cancer	6.28e-05	0.000398	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK1—kidney cancer	6.24e-05	0.000396	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—kidney cancer	6.15e-05	0.00039	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—kidney cancer	6.14e-05	0.00039	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—kidney cancer	5.89e-05	0.000374	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK3—kidney cancer	5.81e-05	0.000369	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—kidney cancer	5.67e-05	0.00036	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—kidney cancer	5.65e-05	0.000359	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—kidney cancer	5.64e-05	0.000358	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK1—kidney cancer	5.53e-05	0.000351	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—kidney cancer	5.46e-05	0.000347	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—kidney cancer	5.41e-05	0.000343	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK3—kidney cancer	5.36e-05	0.00034	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—kidney cancer	5.24e-05	0.000332	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—kidney cancer	5.22e-05	0.000331	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—kidney cancer	5.22e-05	0.000331	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK1—kidney cancer	5.1e-05	0.000324	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—kidney cancer	4.82e-05	0.000306	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—kidney cancer	4.8e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—kidney cancer	4.64e-05	0.000295	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—kidney cancer	4.43e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—kidney cancer	4.29e-05	0.000272	CbGpPWpGaD
